A detailed history of Centiva Capital, LP transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 12,144 shares of TMDX stock, worth $760,821. This represents 0.04% of its overall portfolio holdings.

Number of Shares
12,144
Previous 12,752 4.77%
Holding current value
$760,821
Previous $1.92 Million 0.73%
% of portfolio
0.04%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$135.68 - $176.11 $82,493 - $107,074
-608 Reduced 4.77%
12,144 $1.91 Million
Q2 2024

Aug 14, 2024

SELL
$72.62 - $150.62 $37,326 - $77,418
-514 Reduced 3.87%
12,752 $1.92 Million
Q1 2024

May 15, 2024

BUY
$70.86 - $89.93 $940,028 - $1.19 Million
13,266 New
13,266 $980,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.99B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.